Monday 4th of November
| 10:30 | Inauguration of the Swedish pavilion |
| 11.00 - 11.20 | Unlocking Sweden’s Innovations - Roundtable Host - SwedenBio This seminar delves into Sweden’s key strengths within the life science industry offering broad insights on how the Swedish ecosystem works Panelists: |
| 12.00 - 12.20 | The next frontier for high – impact life science investments - Roundtable Host - Business Region Gothenburg This roundtable unites Nordic cluster leaders, pioneering health startups and international investors for revealing how the region’s unique support models catalyze solutions with the potential to transform global healthcare. Learn how the Nordics are setting new standards for sustainable growth and investor value, positioning the region as the springboard for the next healthcare breakthroughs. Panelists; Anders Waas: GU Ventures, Business Development Lead |
| 13.00 - 13.20 | New antibiotics now! How? - Panel Discussion Host - Umeå Municipality Multi-resistant bacteria are a major threat to modern healthcare. Development of novel antibiotics are necessary to face this. A dysfunctional market for antibiotics have hindered development in the field for a long time. How can society, academia, industry and healthcare come together to make sure we are always ahead of bacterial resistance? |
| 14.00 - 14 .20 | Precisions Medicine Clinical Trials - Stockholm Uppsala Life Science Cluster as a Fast Mover Panel Discussion Host - Region Stockholm, Region Uppsala, Lif and Stockholm Business Region The Stockholm-Uppsala cluster has excellent infrastructural conditions for precision medicine and clinical trials. Sweden is known for world leading clinical data quality for research purposes. Join us in a discussion on how we can utilize these assets to move into a world leading position in precision medicine clinical trials. Panelists: Niclas Blomberg, Director IHI Björn Arvidsson, STUNS Per Lek, SciLifeLab Pontus Holm, Region Stockholm Frida Lundmark, LIF |
| 18.00 - late | Swedish Mixer - Booth Reception Host - Vator Securities |
Tuesday 5th of November
| 09.00 - 09.20 | A Collaborative Pathway for ATMP Development - Roundtable Host - Invest in Skåne |
| 10.00 - 10.20 | The Swedish Collaborative ATMP Ecosystem - Roundtable Host - Vinnova Learn more about the Swedish infrastructure in the ATMP area. How does the collaboration between infrastructures in Sweden work? What value does it create? What can the Swedish infrastructure offer and what value does it provide for companies? Panelists: Janet Hoogstraate, NorthXBiologics Fredrik Wessberg, CCRM Nordic Alexandra Patriksson, Cytiva Karin Stenström, Vinnova Elisabet Nielsen, Vinnova |
| 11.00 - 11.20 | Manufacturing in Sweden: Innovation meets sustainability - Roundtable Host - SwedenBio The seminar highlights Sweden’s leadership in pharmaceutical manufacturing, where cutting-edge innovation aligns with sustainable practices. This seminar explores advanced production techniques, eco-friendly initiatives, and Sweden’s role in shaping a greener, more efficient pharma industry, offering valuable insights into sustainable growth and global competitiveness. Panelists: |
| 11.00 - 12.00 | Meet SwedenBIO’s Business Strategy Working Group at the Swedish Pavillion Need some advice for your upcoming partnering meeting or how to follow-up after a promising meeting? Meet members of SwedenBIO’s Business Strategy Working Group at the Swedish Pavillion on Monday 4th and Tuesday 5th 11-12. Christina Herder, Co-founder and CEO of Cell4Cure AB |
| 12.00 - 12.20 | Synergies in science: Swedish and global investors in Life Science - Roundtable Host - Business Sweden |
| 13.00 - 13 .20 | Masters of collaborations for ATMP - Roundtable Host - Business Region Gothenburg Explore how collaborations among organizations, clusters, and industry players are driving the scale-up of advanced medical products and Healthtech innovations, in general. We'll address bottlenecks, share business models, and uncover engagement opportunities to equip investors, startups, and companies with the relevant tools for business growth and market success. Panelists: Fredrik Wessberg: CCRM Nordic, CEO |
| 14.00 - 14.20 | ALS: Research for early detection and prevention - Roundtable Host - Umeå municipality ALS causes late-stage symptoms, leaving the patients and healthcare systems with limited treatment options and poor prognosis. There is a vital need for pre-symptomatic diagnosis, for relatives of patients with familial and sporadic ALS. What is needed to advance this field from society, academia, industry and healthcare? |
| 16.00 - 16.20 | Precisions Medicine Clinical Trials - Stockholm Uppsala Life Science Cluster as a Fast Mover -Host - Region Stockholm, Region Uppsala, Lif and Stockholm Business Region The Stockholm-Uppsala cluster has excellent infrastructural conditions for precision medicine and clinical trials. Sweden is known for world leading clinical data quality for research purposes. Join us in a discussion on how we can utilize these assets to move into a world leading position in precision medicine clinical trials. Panelists: Niclas Blomberg, Director IHI Björn Arvidsson, STUNS Anna Wedell, Precision Medicine Center Karolinska Per Lek, SciLifeLab Pontus Holm, Region Stockholm |
Wednesday 6th of November
| 09.00 - 09.20 | Case study from Skåne: Asgard Therapeutics - Roundtable Host - Invest in Skåne |
| 10.00 - 10.20 | Medtech: Essential to the Fight Against Antibiotic Resistance - Roundtable Host - MedTech4Health Cutting-edge medical technologies are crucial in addressing the global threat of antibiotic resistance. Swedish innovators are offering advanced solutions for rapid diagnostics, infection prevention, and monitoring, reducing the reliance on antibiotics and paving the way for a healthier, more sustainable future. |
| 11.00 - 11.20 | Innovative Swedish Deeptech - Roundtable Host - MedTech4Health Swedish deep-tech companies are pioneering advanced technologies for the future of healthcare. These companies are leveraging innovations such as bioprinting, biophotonics, bioengineering, nanotechnology, neurotechnology, and 3D scanning and imaging to push the boundaries of medical innovation. They are offering new treatments, diagnostics, and devices to improve patient outcomes |